Protein binding of homocysteine and other thiols in HeLa cell cultures after addition of homocysteine and copper ions

Clinica Chimica Acta

Volumn 269, Issue 2, 1998, Pages 175-184

  Hultberg, B ^a   Andersson, A ^a   Isaksson, A ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cell culture; Copper ions; Cysteine; Disulfide bond; Glutathione; Homocysteine; Protein binding

Indexed keywords

COPPER ION; CYSTEINE; DISULFIDE; GLUTATHIONE; HOMOCYSTEINE; THIOL DERIVATIVE;

ARTICLE; ATHEROSCLEROSIS; CELL CULTURE; CONTROLLED STUDY; DISULFIDE BOND; HELA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING;

COPPER; CYSTEINE; GLUTATHIONE; HELA CELLS; HOMOCYSTEINE; HUMANS; PROTEIN BINDING;

EID: 0032579131     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(97)00197-6     Document Type: Article

References (27)

1. Mudd SH, Harvey LL, Skovby F. Disorders of trans-sulfuration. In: Scriver, Beaudet, Sly, Valle, editors. The metabolic basis of inherited disease. Sixth ed. McGraw-Hill, 1989:693-734.
2. Brattström L, Hardebo J, Hultberg B Moderate homocysteinemia - a possible risk factor for arteriosclerotic cerebrovascular disease. Stroke. 15:1984;1012-1016.
3. Boers GHJ, Smals AGH, Tribels FJM, Fowler B, Bakkeren JAJM, Schoonderwaldt HC, Kleijer WJ, Kloppenborg PWC Heterozygoti for homocysteinuria in premature peripheral and cerebral occlusive arterial disease. N Engl J Med. 313:1985;709-715.
4. Malinow MR, Kang SS, Taylor LM, Wong PWK, Coull B, Inahara T, Mukerjee D, Sexton G, Upton B Prevalence of hyperhomocysteinemia in patients with peripheral arterial occlusive disease. Circulation. 79:1989;1180-1189.
5. Clarke R, Leslie D, Robinson K, Naughten E, Calahane S, Fowler B, Graham I Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med. 324:1991;1149-1155.
6. Stampfer MJ, Malinow MR, Willet WC, Newcomer LM, Upson B, Ullman D, Tishler PV, Henneken CH A prospective study of plasma homocysteine and risk of myocardial infarction in US physicians. J Am Med Assoc. 268:1992;877-881.
7. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intake. J Am Med Assoc. 274:1995;1049-1056.
8. Malinow MR Plasma homocysteine and arterial occlusive diseases. A mini-review. Clin Chem. 41:1995;173-176.
9. Meister A Glutathione metabolism and its selective modification. J Biol Chem. 263:1988;17205-17208.
10. Starkebaum G, Harlan JM Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J Clin Invest. 77:1986;1370-1376.
11. Berman RS, Martin W Arterial endothelial barrier dysfunction: actions of homocysteine and the hypoxanthine oxidase free radical generating system. Br J Pharmacol. 108:1993;920-926.
12. Loscalzo J The oxidant stress of hyperhomocysteinemia. J Clin Invest. 98:1996;5-7.
13. Jocelyn PC. Chemical reactions of thiols. In: Biochemistry of the SH group. London: Academic Press, 1972:116-136.
14. Andersson A, Isaksson A, Brattström L, Hultberg B Homocysteine and other thiols determined in plasma by HPLC and thiol-specific post-column derivatization. Clin Chem. 39:1993;1590-1597.
15. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ Protein measurements with Folin reagent. J Biol Chem. 193:1951;265-275.
16. Hultberg B, Andersson A, Isaksson A Metabolism of homocysteine, its relation to the other cellular thiols and its mechanism of cell damage in a cell culture line (human histiocytic cell line U-937). Biochim Biophys Acta. 1269:1995;6-12.
17. Hultberg B, Andersson A, Isaksson A Copper ions differ from other metal ions in their effects on the concentration and redox status of thiols in HeLa cell cultures. Toxicology. 117:1997;89-97.
18. Hultberg B, Andersson A, Isaksson A The effects of homocysteine and copper ions on the concentration and redox status of thiols in cell line cultures. Clin Chim Acta. 262:1997;39-51.
19. Mansoor M.A., Guttormsen A.B., Fiskerstrand T., Refsum H., Ueland P.M., Svardal A.M. Redox status and protein binding of plasma aminothiols during the transient hyperhomocysteinemia that follows homocysteine administration. Clin Chem. 39:1993;980-985.
20. Ueland PM Homocysteine species as component of plasma redox thiol status. Clin Chem. 41:1995;340-342.
21. Mansoor MA, Bergmark C, Svardal AM, Lonning PE, Ueland PM Redox status and protein binding of plasma homocysteine and other aminothiols in patients with early-onset peripheral vascular disease. Arterio Thromb Vasc Biol. 15:1995;232-240.
22. Andersson A, Lindgren A, Hultberg B Effect of thiol oxidation and thiol export from erythrocytes on determination of redox status of homocysteine and other thiols in plasma from healthy subjects and patients with cerebral infarction. Clin Chem. 41:1995;361-366.
23. Freedman JH, Ciriolo MR, Peisach J The role of glutathione in copper metabolism and toxicity. J Biol Chem. 264:1989;5598-5605.
24. Cartana J, Romeu A, Arola L Effect of copper, cadmium and nickel on liver and kidney glutathione redox cycle of rats. Comp Biochem Physiol. 101C:1992;209-213.
25. Steinebach OM, Wolterbeek HT Effects of copper on rat hepatoma HTC cells and on primary cultured rat hepatocytes. J Inorg Biochem. 53:1994;27-48.
26. Mele MC, Meucci E Homocysteine and oxidative modification of plasma proteins. Amino Acids. 11:1996;99-104.
27. Blundell G, Jones BG, Rose FA, Tudball N Homocysteine mediated endothelial cell toxicity and its amelioration. Atherosclerosis. 122:1996;163-172.